Myomo Secures Initial In-Network Private Payer Contracts
Myomo, Inc. (NYSE American: MYO) is making waves in the medical robotics sector. This forward-thinking company is dedicated to improving the quality of life for individuals facing neurological challenges and upper-limb paralysis. Recently, it announced a significant development: the establishment of its first contracts for providing MyoPro to patients under private insurance coverage. This momentous step aims to facilitate better access to innovative treatments.
Partnerships with Leading Insurers
The newly formed contracts involve two prominent organizations: Blue Cross Blue Shield of Massachusetts and Paradigm. Blue Cross Blue Shield, a notable commercial and Medicare Advantage insurer, is dedicated to maintaining community welfare and offering essential healthcare benefits. Paradigm, on the other hand, focuses on specialty care management, ensuring that those with workers' compensation claims have access to critical medical innovations such as MyoPro. Collectively, these companies serve around 3 million individuals, demonstrating the potential for profound change in patient care.
A Key Milestone for Myomo
Comments from Leadership
Harry Kovelman, M.D., Myomo’s chief medical officer, expressed enthusiasm about this milestone. He stated, “Entry into these first in-network payer contracts represents a key milestone for Myomo and an expansion of coverage for patients suffering from neurological disorders and upper-limb paralysis.” His comments underscore the importance of expanding coverage to ensure that patients regain their independence and improve their daily living experiences.
Continued Outreach to Private Payers
Myomo is committed to pursuing further partnerships with additional private payers. The enthusiastic reception received so far indicates a positive trajectory for their efforts. With existing coverage now extended through Medicare Part B, more insurers are starting to recognize the value of the MyoPro. The company believes this device can evolve into the standard of care for those suffering from permanent upper extremity impairment.
About Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Massachusetts is a not-for-profit health plan focused on ensuring equitable healthcare access. Headquartered in Boston, this organization separates itself through its dedication to leading with member satisfaction and quality care. Their commitment reflects positively in rankings that acknowledge their exceptional service.
About Paradigm
Paradigm is known for its pioneering work in specialty care management since 1991. The organization emphasizes value-based care, making significant strides towards enhancing the lives of individuals with complex diagnoses and injuries. Through their robust risk-based clinical solutions and strong emphasis on quality outcomes, Paradigm continues to set an example for the industry.
About Myomo
Myomo, Inc. specializes in wearable medical robotics. Its flagship product, the MyoPro, is designed to assist patients facing neurological disorders and upper-limb paralysis. This pioneering device is unique in the U.S. market; it utilizes a patient's own EMG signals to facilitate movement, allowing them to perform daily activities more independently. By addressing the needs of individuals recovering from strokes, spinal injuries, and other diseases, Myomo stands at the forefront of medical technology aimed at restoring functionality and enhancing quality of life.
Frequently Asked Questions
What is MyoPro?
MyoPro is a powered upper-limb orthosis developed by Myomo to aid individuals with neurological disorders and upper-limb paralysis in restoring arm function.
Who is covered under the new contracts?
The newly established in-network contracts allow patients covered by Blue Cross Blue Shield of Massachusetts and Paradigm to access MyoPro services.
What impact do these contracts have on patients?
These contracts increase accessibility to MyoPro, empowering patients with upper-limb paralysis to regain independence in daily activities.
How does Myomo's technology work?
MyoPro detects EMG signals from the user’s muscles, using this information to drive movement in the device, allowing for improved functionality.
Can MyoPro help patients return to work?
Yes, many patients using MyoPro report increased capabilities that enable them to return to work and live independently.
